Effects of Smoking on Clinical and Microbiological Response in Individuals With Periodontitis
Launched by TRAKYA UNIVERSITY · Apr 24, 2024
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
The present study aims to compare the changes in clinical parameters and subgingival periodontopathogen rates (P. gingivalis, A. actinomycetemcomitans, T. forsythia, F. nucleatum, P. intermedia, T. denticola, P. micra, C. rectus, E. nodatum, Capnocytophaga spp, and E. corrodens) following full-mouth scaling and root planing procedures in participants with and without smoking habits.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having 15 or more permanent teeth (except third molars and teeth with endodontic lesions),
- • Having been diagnosed with generalized Stage III or IV periodontitis that progresses with periodontal support tissue loss in more than 30% of the teeth,
- • Having at least five teeth with probing depth(PD) ≥6mm, clinical attachment level(CAL) ≥5mm, and radiographic bone loss that extends to at least the middle of the root,
- • Having at least one tooth that meets the same PD and CAL criteria per quadrant.
- Exclusion Criteria:
- • Pregnancy or lactation,
- • Any systemic disease with a potential influence on the immune response (diabetes mellitus, bone metabolic diseases, immunosuppressive therapy, radiation etc.),
- • Existence of decay, restoration, or prosthesis on the sampling site,
- • Use of the anti-inflammatory drug and antibiotic within the last 3 months.
About Trakya University
Trakya University is a leading academic institution located in Edirne, Turkey, dedicated to advancing health sciences through innovative research and education. With a strong emphasis on clinical trials, the university fosters collaboration between researchers, healthcare professionals, and industry partners to facilitate groundbreaking studies that enhance patient care and medical knowledge. Trakya University's commitment to ethical standards, rigorous scientific methodology, and community engagement positions it as a key player in the landscape of clinical research, contributing to the development of novel therapeutic interventions and improving health outcomes in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edirne, Edi̇rne, Turkey
Patients applied
Trial Officials
Ece Açıkgöz-Alparslan
Principal Investigator
Trakya University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported